ANIK 17.18 (+0.82%)
US0352551081BiotechnologyBiotechnology

Anika Therapeutics (ANIK) Stock Highlights

17.18 | +0.82%
2024-11-21 05:14:24
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of revenue from the United States.

Statistics

Range Today
16.82 17.22
Volume Today 168.3K
Range 1 Year
16 29.12
Volume 1 Year 18.15M
Range 3 Year
16 41.19
Volume 3 Year 71.25M
Range 10 Year
16 75.72
Volume 10 Year 316.1M

Highlights

Market Capitalization 252.78M (small)
Floating Shares 10.63M
Current Price 17.18
Price To Earnings -2.59
Price To Revenue 1.33
Price To Book 1.41
Earnings Per Share -6.64
Payout Ratio 0%

Performance

Latest +0.82%
1 Month -31.14%
3 Months -35.15%
6 Months -32.63%
1 Year -17.8%
3 Years -57.39%
5 Years -71.25%
10 Years -56.87%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.